Eliezer M. Van Allen

Affiliations: 
Dana Farber Cancer Institute, Harvard Medical School 
Area:
Cancer genomics
Google:
"Eliezer Van Allen"
Mean distance: (not calculated yet)
 

Parents

Sign in to add mentor
Levi A. Garraway grad student (Cell Biology Tree)

Collaborators

Sign in to add collaborator
Myles Brown collaborator (Cell Biology Tree)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Gil Del Alcazar CR, Trinh A, Aleckovic M, et al. (2022) Insights into immune escape during tumor evolution and response to immunotherapy using a rat model of breast cancer. Cancer Immunology Research
Dietlein F, Wang AB, Fagre C, et al. (2022) Genome-wide analysis of somatic noncoding mutation patterns in cancer. Science (New York, N.Y.). 376: eabg5601
Stover EH, Oh C, Keskula P, et al. (2022) Implementation of a prostate cancer-specific targeted sequencing panel for credentialing of patient-derived cell lines and genomic characterization of patient samples. The Prostate
Bakouny Z, Sadagopan A, Ravi P, et al. (2022) Integrative clinical and molecular characterization of translocation renal cell carcinoma. Cell Reports. 38: 110190
Kehl KL, Xu W, Gusev A, et al. (2021) Artificial intelligence-aided clinical annotation of a large multi-cancer genomic dataset. Nature Communications. 12: 7304
De Sarkar N, Dasgupta S, Chatterjee P, et al. (2021) Genomic attributes of homology-directed DNA repair deficiency in metastatic prostate cancer. Jci Insight. 6
Cejas P, Xie Y, Font-Tello A, et al. (2021) Subtype heterogeneity and epigenetic convergence in neuroendocrine prostate cancer. Nature Communications. 12: 5775
Bekele RT, Samant AS, Nassar AH, et al. (2021) RAF1 amplification drives a subset of bladder tumors and confers sensitivity to MAPK-directed therapeutics. The Journal of Clinical Investigation
Keenan TE, Guerriero JL, Barroso-Sousa R, et al. (2021) Molecular correlates of response to eribulin and pembrolizumab in hormone receptor-positive metastatic breast cancer. Nature Communications. 12: 5563
Tewari AK, Cheung ATM, Crowdis J, et al. (2021) Molecular features of exceptional response to neoadjuvant anti-androgen therapy in high-risk localized prostate cancer. Cell Reports. 36: 109665
See more...